GL1X · GenesisL1 explorer

Research workbench

Modified Form of Eosinophil-derived Neurotoxin

Analyse Modified Form of Eosinophil-derived Neurotoxin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1K2A
Type
protein
Length
136 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1
Source
Homo sapiens
Molecule
eosinophil-derived neurotoxin
EC
3.1.27.5
UniProt
P10153
Ligands
SO4
Pockets
1 · best druggability 0.43

Structure

x-ray diffraction · resolution 1 · 1 distinct chain · 23% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
Aeosinophil-derived neurotoxin (EC 3.1.27.5)protein13623% helix, 32% strandP10153

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.430.7627SO4

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1K2A · Modified form of eosinophil-derived neurotoxin · the same entry in another collection · chain A against A, TM-score 1.00
  • P10153 · AlphaFold monomer V2.0 prediction for non-secretory ribonuclease (P10153) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.